Proteomics Market Anticipated to Grow at CAGR of 17.6% by 2033 | Persistence Market Research

Proteomics plays a crucial role in developing targeted therapies and diagnostics tailored to individual patients genetic makeup and protein expression.

New York, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The high prevalence of target diseases and the rising demand for personalised medicines and advanced diagnostics in the treatment of targeted diseases are key factors promoting market growth. The market will grow as more focus is given to product usage in drug discovery, biomarker research, and clinical diagnostics for the detection and treatment of diseases. Worldwide revenue from the proteomics market was about US$ 30.8 Billion in 2022, with the global market estimated to surge ahead at a CAGR of 17.6% to reach a valuation of US$ 181.5 Billion by the end of 2033.

For example, in June 2022, scientists at the Indian Institute of Science in Bangalore developed a special kind of tiny proteins that can fight viruses like SARS-CoV-2. These proteins can also group together virus particles to make them less harmful and prevent them from entering human cells. This kind of research and development is expected to boost the market even further.

Another reason for the market's growth is the increase in chronic diseases like cancer, heart problems, and respiratory diseases. In December 2020, there were 10.6 million cancer-related deaths and 19.3 million new cancer cases worldwide. Similarly, heart diseases are one of the top causes of death worldwide, with about 41 million people dying from these diseases each year according to the World Health Organization in 2021. Because of these life-threatening diseases, there's a growing need for personalized medicines, which is good for the market.

So, it's likely that the global proteomics market will keep growing at a fast rate, with an estimated yearly increase of 17.6%, and it could reach a total market size of US$ 181.5 Billion by the year 2033.

Seeking Deeper Insights into Competitor Analysis? Request a Sample of the Report Now! https://www.persistencemarketresearch.com/samples/31378

Proteomics Market Report Scope:

 Report Coverage

 Details

Market Revenue 2022

US$ 30.8 Billion

Estimated Revenue 2033

US$ 181.5 Billion

Growth Rate – CAGR

17.6%

 

Forecast Period

2023-2033

No. of Pages

247 Pages



 Key Market Segments Covered

  • Component

  • Technology

  • Application

  • End User

  • Region



 Regions Covered

  • North America

  • Latin America

  • Europe

  • South Asia

  • East Asia

  • Oceania

  • Middle East & Africa







 Key Companies Profiled

  • Agilent Technologies, Inc.

  • Thermo Fisher Scientific, Inc.

  • GE Healthcare

  • Danaher Corporation

  • PerkinElmer, Inc.

  • Merck KGaA

  • Caprion Proteomics Inc.

  • Bio-Rad Laboratories

  • Luminex Corporation

  • Waters Corporation

  • Promega Corporation

  • Bruker Corporation

Proteomics Market Dynamics

Drivers:

The global proteomics market is experiencing substantial growth, driven primarily by advancements in technology. These technological breakthroughs have revolutionized the field of proteomics, significantly enhancing sensitivity, resolution, and enabling high-throughput, multiplexed analysis. They have also improved data integration, sample preparation techniques, and fractionation methods, while facilitating mass spectrometry-based imaging. Moreover, advanced data analysis and informatics tools have played a pivotal role in expanding our understanding of the proteome. These innovations have accelerated biomarker discovery, spurred progress in personalized medicine, and streamlined drug discovery and development. Overall, technological advancements have broadened the horizons of proteomics research, enabling comprehensive exploration of proteins in various biological contexts. These breakthroughs have resulted in a deeper comprehension of protein functions, disease mechanisms, drug discovery, and personalized medicine, thus fueling the growth and impact of proteomics as a field of study.